Navigation Links
IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards
Date:3/17/2009

Alexandria, Va. The International Association for Dental Research (IADR) and GlaxoSmithKline (GSK) Consumer Healthcare today announced the 2009 winners of the annual IADR/GSK Innovation in Oral Care Awards. The three prestigious awards recognize research in innovative oral care technologies that may maintain and improve oral health and the quality of life.

In its sixth year of award support, GSK Consumer Healthcare has contributed nearly $1.4 million. Each of the three 2009 winners will receive a $75,000 unrestricted research grant, which is funded by GSK Consumer Healthcare and administered by IADR. The 2009 winners are:

  • Eric Reynolds, B.Sc., Ph.D., The University of Melbourne School of Dental Science, Australia, for "Development of Oxantel to Prevent Periodontopathogenic Biofilm Formation." Oxantel is already approved for use in humans at relatively high concentrations as a treatment for intestinal parasites. Reynolds and his team have patented its use for the treatment of periodontal diseases. Once the efficacy of Oxantel against periodontopathogenic bacterial biofilms has been demonstrated, it should be possible to develop a professional product that will result in improved oral health for persons with periodontitis.

  • Rena D'Souza, B.D.S., M.S., D.D.S., Ph.D., Baylor College of Dentistry, Texas A&M Health Science Center in Dallas, USA, for "Nanostructured Peptide Hydrogels and Stem Cells for Dentin-Pulp Complex Regeneration." This innovative research will develop and test novel peptide-based hydrogels as scaffolds to promote the differentiation of adult stem cells and the formation of dentin and pulp tissues. This biologically based endodontic therapy offers an important alternative for individuals in a clinical situation with an otherwise poor prognosis.

  • Sandra Bordin, Ph.D., The University of Washington School of Dentistry, Seattle, USA, for "Optical Coherence Tomography for Non-invasive Diagnosis of
    '/>"/>

Contact: Ingrid Thomas
IThomas@iadr.org
703-299-8084
International & American Association for Dental Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... TX (PRWEB) May 24, 2015 For ... Global and Chinese Enterokinase Industry, 2009-2019 Market Research Report ... it is an exhaustive study on the present market ... special insight into the growing Chinese market of this ... and the overall status of the manufacturers in this ...
(Date:5/24/2015)... EnviroLeather™ by LDI, a leader in ... classic, rugged leather grain with enhanced stain resistance ... ink, to be easily removed. The collection is ... healthcare, hospitality and education environments. , InkGard Plus ... developing products that are more sustainable, less toxic ...
(Date:5/24/2015)... 24, 2015 Indiana Fiber Network, LLC ... Midwest Telecom of America, Inc. (MTA) has selected IFN ... Cory Childs, IFN Enterprise Sales Manager, fiber route diversity ... “IFN’s fiber transport provides MTA with the diverse fiber ... Tier 1 Internet and voice carriers located at Henry ...
(Date:5/24/2015)... CA (PRWEB) May 24, 2015 ... clear indicator that the single best option for avoiding ... reveals that fitness level was the single most powerful ... for variables such as diabetes and family history of ... of maintaining lifelong heart and lung fitness. , The ...
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
Breaking Medicine News(10 mins):Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2
... NYSE Agrees to a Trading Extension of KV,s Securities until February ... ... 2008, ST. LOUIS, Dec. 28 KV Pharmaceutical Company,(NYSE: ... markets technology differentiated,branded and generic/non-branded prescription pharmaceutical products,announced today that NYSE ...
... restricted calorie intake for diabetics wanting to manage their ... the first time, the American Diabetes Association (ADA) has ... with diabetes who want to manage their weight. , ... low-carbohydrate diets in its newly published 2008 clinical ...
... (NYSE: MYL ),today announced that Mylan Pharmaceuticals Inc. ... Administration (FDA) for its Abbreviated New,Drug Application (ANDA) for ... Cetirizine HCl Tablets are the generic version of Pfizer,s ... for the 12,months ending Sept. 30, 2007., This ...
... December 28, 2007 In the United States, the ... Of the $1.9 billion in direct costs, glaucoma medications ... total. In an article published in the January 2008 ... The Texas A&M University System Health Science Center College ...
... an Interactive Arcade for Kids, Teens, and Adult Gamers ... largest 59,000,sq. ft. Mega-Center officially opened for workouts on ... Chester just off Cincinnati-Dayton,Road & I-75 next to Wal-Mart. ... which includes a silent auction on Saturday, January,19th from ...
... ATLANTA, Dec. 27 Eclipsys Corporation(R),(Nasdaq: ECLP ... be,participating in the 2008 JPMorgan Healthcare Conference taking ... CA., (Logo: http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO ), ... Tuesday, January,8th at 3:00 p.m. Pacific time. To ...
Cached Medicine News:Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 2Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 3Health News: Diabetes Group Backs Low-Carb Diets 2Health News:Cost of glaucoma medications may impact treatment 2Health News:Fitworks West Chester Mega-Center Now Open 2Health News:Fitworks West Chester Mega-Center Now Open 3Health News:Eclipsys to Present at JPMorgan Healthcare Conference 2Health News:Eclipsys to Present at JPMorgan Healthcare Conference 3
(Date:5/21/2015)... May 21, 2015  When Ryan Rendino ... side of his neck, he figured it ... couple weeks off from weight lifting. ...                               A series of ... referred to Michel Kliot, MD , ...
(Date:5/21/2015)... , May 21, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... quarterly cash dividend for the second quarter 2015 of ... cash dividend of $0.03 per share will be paid ... record as of June 12, 2015.  The ex-dividend date ...
(Date:5/21/2015)... 21. Mai 2015 Dipexium ... ein Unternehmen für Arzneimittel im fortgeschrittenen ... und Vermarktung von Locilex® (Pexiganan-Creme 0,8 %) ... eine wissenschaftliche Posterpräsentation an, welche das ... vorstellt, OneStep-1 und OneStep-2, in der ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... , ALBUQUERQUE, N.M. , ... molecular diagnostics laboratory that discovers, develops and markets proprietary ... agreement with EndoChoice, Inc. to promote its diagnostic services ... Under the agreement, EndoChoice,s experienced, gastroenterology-focused sales force will ...
... , DULUTH, Ga. , Feb. 16 ... from the U.S. Department of Agriculture for ONCEPT™ Canine Melanoma ... in extending survival of dogs with stage II or stage ... cancer in dogs. , ONCEPT is the first and ...
Cached Medicine Technology:Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice 2MERIAL Receives Full License Approval for ONCEPT(TM) Canine Melanoma Vaccine 2MERIAL Receives Full License Approval for ONCEPT(TM) Canine Melanoma Vaccine 3MERIAL Receives Full License Approval for ONCEPT(TM) Canine Melanoma Vaccine 4MERIAL Receives Full License Approval for ONCEPT(TM) Canine Melanoma Vaccine 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: